-+ 0.00%
-+ 0.00%
-+ 0.00%

Watching Corvus Pharmaceuticals; CNBC Reports "This biopharma stock could more than double on oral eczema treatment, Goldman Sachs says"

Benzinga·04/17/2026 16:33:23
Listen to the news